Kutuzov M, Sayfullina D, Belousova E, Lavrik O
Int J Mol Sci. 2025; 26(5).
PMID: 40076422
PMC: 11898694.
DOI: 10.3390/ijms26051794.
Farrokhi Yekta R, Farahani M, Koushki M, Amiri-Dashatan N
Front Oncol. 2024; 14:1481426.
PMID: 39497715
PMC: 11532047.
DOI: 10.3389/fonc.2024.1481426.
Bernasocchi T, Mostoslavsky R
Front Epigenet Epigenom. 2024; 2.
PMID: 39239102
PMC: 11375787.
DOI: 10.3389/freae.2024.1451971.
Yang Y, Zhang M, Wang Y
J Natl Cancer Cent. 2024; 2(4):277-290.
PMID: 39036551
PMC: 11256729.
DOI: 10.1016/j.jncc.2022.09.002.
Dhahri H, Saintilnord W, Chandler D, Fondufe-Mittendorf Y
Int J Mol Sci. 2024; 25(12).
PMID: 38928493
PMC: 11203562.
DOI: 10.3390/ijms25126788.
PARticular MARks: Histone ADP-ribosylation and the DNA damage response.
Ozdemir C, Purkey L, Sanchez A, Miller K
DNA Repair (Amst). 2024; 140:103711.
PMID: 38924925
PMC: 11877395.
DOI: 10.1016/j.dnarep.2024.103711.
Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.
Akram F, Tanveer R, Andleeb S, Shah F, Ahmad T, Shehzadi S
Technol Cancer Res Treat. 2024; 23:15330338241250317.
PMID: 38780251
PMC: 11119348.
DOI: 10.1177/15330338241250317.
Hungry for control: metabolite signaling to chromatin in Plasmodium falciparum.
Lappalainen R, Kumar M, Duraisingh M
Curr Opin Microbiol. 2024; 78:102430.
PMID: 38306915
PMC: 11157454.
DOI: 10.1016/j.mib.2024.102430.
Catalytic activity of OGG1 is impaired by Zinc deficiency.
Sharma P, Wong C, Ho E, Sampath H
DNA Repair (Amst). 2024; 134:103628.
PMID: 38228016
PMC: 10851324.
DOI: 10.1016/j.dnarep.2024.103628.
PARylated PDHE1α generates acetyl-CoA for local chromatin acetylation and DNA damage repair.
Zhang J, Chen F, Tian Y, Xu W, Zhu Q, Li Z
Nat Struct Mol Biol. 2023; 30(11):1719-1734.
PMID: 37735618
DOI: 10.1038/s41594-023-01107-3.
Epigenetic Mechanisms of Aging and Aging-Associated Diseases.
la Torre A, Lo Vecchio F, Greco A
Cells. 2023; 12(8).
PMID: 37190071
PMC: 10136616.
DOI: 10.3390/cells12081163.
Targeting epigenetic regulators to overcome drug resistance in cancers.
Wang N, Ma T, Yu B
Signal Transduct Target Ther. 2023; 8(1):69.
PMID: 36797239
PMC: 9935618.
DOI: 10.1038/s41392-023-01341-7.
The Role of PARP1 and PAR in ATP-Independent Nucleosome Reorganisation during the DNA Damage Response.
Belousova E, Lavrik O
Genes (Basel). 2023; 14(1).
PMID: 36672853
PMC: 9859207.
DOI: 10.3390/genes14010112.
Characterizing crosstalk in epigenetic signaling to understand disease physiology.
Lempiainen J, Garcia B
Biochem J. 2023; 480(1):57-85.
PMID: 36630129
PMC: 10152800.
DOI: 10.1042/BCJ20220550.
Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment.
Mohammad A, Jha S
Cancers (Basel). 2023; 15(1).
PMID: 36612210
PMC: 9818548.
DOI: 10.3390/cancers15010215.
Poly(ADP-ribosyl)ating enzymes cooperate to coordinate development.
Bordet G, Karpova I, Tulin A
Sci Rep. 2022; 12(1):22120.
PMID: 36543866
PMC: 9772176.
DOI: 10.1038/s41598-022-26530-2.
Epigenetic Reprogramming of the Glucose Metabolic Pathways by the Chromatin Effectors During Cancer.
Mondal P, Tiwary N, Sengupta A, Dhang S, Roy S, Das C
Subcell Biochem. 2022; 100:269-336.
PMID: 36301498
DOI: 10.1007/978-3-031-07634-3_9.
Histone modification in podocyte injury of diabetic nephropathy.
Wang S, Zhang X, Wang Q, Wang R
J Mol Med (Berl). 2022; 100(10):1373-1386.
PMID: 36040515
DOI: 10.1007/s00109-022-02247-7.
Oncohistone Mutations Occur at Functional Sites of Regulatory ADP-Ribosylation.
Huang D, Camacho C, Martire S, Nagari A, Setlem R, Gong X
Cancer Res. 2022; 82(13):2361-2377.
PMID: 35472077
PMC: 9256803.
DOI: 10.1158/0008-5472.CAN-22-0742.
Protein post-translational modifications in the regulation of cancer hallmarks.
Wang H, Yang L, Liu M, Luo J
Cancer Gene Ther. 2022; 30(4):529-547.
PMID: 35393571
DOI: 10.1038/s41417-022-00464-3.